| CUE BIOPHARM.INC. DL-,001 |
| USA |
| Gesundheit |
| US22978P1066 / A2JAT5 |
| 1UC (Frankfurt) / CUE (NASDAQ) |
| FRA:1UC, ETR:1UC, 1UC:GR, NASDAQ:CUE |
| - |
| https://www.cuebiopharma... |
|
Cue Biopharma Inc. is a biotechnology company focu..
>Volltext.. |
| 37.12 Mio. EUR |
| 26.46 Mio. EUR |
| 6.1 Mio. EUR |
| -32.7 Mio. EUR |
| -32.37 Mio. EUR |
| -0.39 EUR |
| 5.3 Mio. EUR |
| 10.05 Mio. EUR |
| -25.46 Mio. EUR |
| 1.2 |
| -29.32% |
| 19.85% |
| - |
| - |
| - |
| - |
| CUE BIOPHARMA |
| 07.12.25 |
|
||||
|